Parent Educational Discharge Support Strategies

NCT03227068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 289

Last updated 2020-06-30

No results posted yet for this study

Summary

After the initial hospitalization, parents of children newly diagnosed with cancer assume responsibility for assessing and managing their care; however, parents are often overwhelmed with information received throughout the hospitalization and are apprehensive about caring for their child at home. Parents want concise, focused information on how to care for their child after the hospital discharge. Two parent education discharge support strategies (PEDSS) were created to use at hospital discharge. PEDSS consists of a symptom management intervention and a support for the caregiver intervention. A cluster randomized control trial will assess the effectiveness and feasibility of the two different interventions.

Conditions

  • Educational Activities

Interventions

OTHER

PEDSS - symptom management

All subjects will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge, which includes a list of home medications and information regarding whom to call for emergencies. The PEDSS - symptom management will be delivered prior to the initial hospital discharge. The nurse will review the symptom management worksheet verbally with the parent, then distribute the written worksheet to the parent.

OTHER

PEDSS - support for the caregiver

All subjects will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge, which includes a list of home medications and information regarding whom to call for emergencies. The PEDSS - support for the caregiver will be delivered prior to the initial hospital discharge. The nurse will review the worksheet verbally with the parent, then distribute the written worksheet to the parent.

Sponsors & Collaborators

  • Children's Health System of Texas Children's Medical Center

    collaborator UNKNOWN
  • Cohen Children's Medical Center

    collaborator OTHER
  • Levine Children's Hospital

    collaborator OTHER
  • Lurie Children's Hospital of Chicago

    collaborator UNKNOWN
  • Maine Children's Cancer Program at Maine Medical Center

    collaborator UNKNOWN
  • Medical University of South Carolina Children's Hospital

    collaborator UNKNOWN
  • Nationwide Children's Hospital

    collaborator OTHER
  • Northwestern Medicine Central DuPage Hospital

    collaborator UNKNOWN
  • St. Jude Children's Research Hospital

    collaborator OTHER
  • St. Louis Children's Hospital

    collaborator OTHER
  • St. Peter's University Hospital

    collaborator UNKNOWN
  • University of Wisconsin Health American Children's Hospital

    collaborator UNKNOWN
  • West Virginia Univeristy Medicine

    collaborator UNKNOWN
  • King Faisal Specialist Hospital & Research Center

    collaborator OTHER
  • Nicklaus Children's Hospital

    collaborator UNKNOWN
  • Duke University

    lead OTHER

Principal Investigators

  • Marilyn Hockenberry, PhD · Duke University

  • Megan Arthur, BS · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-29
Primary Completion
2020-06-29
Completion
2020-06-29

Countries

  • United States
  • Saudi Arabia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03227068 on ClinicalTrials.gov